Maddin, N. (2017). Influence of ORM1, PXR, CAR, CYP3A4 and CYP3A5 gene polymorphisms in mediating susceptibility risk to chronic myeloid leukaemia and response to imatinib mesylate therapy.
Chicago Style (17th ed.) CitationMaddin, Najlaa. Influence of ORM1, PXR, CAR, CYP3A4 and CYP3A5 Gene Polymorphisms in Mediating Susceptibility Risk to Chronic Myeloid Leukaemia and Response to Imatinib Mesylate Therapy. 2017.
MLA (9th ed.) CitationMaddin, Najlaa. Influence of ORM1, PXR, CAR, CYP3A4 and CYP3A5 Gene Polymorphisms in Mediating Susceptibility Risk to Chronic Myeloid Leukaemia and Response to Imatinib Mesylate Therapy. 2017.
Warning: These citations may not always be 100% accurate.